These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3558340)

  • 1. Aluminium loading during therapeutic plasma exchange.
    Monteagudo F; Wood L; Jacobs P; Folb P; Cassidy M
    J Clin Apher; 1987; 3(3):161-3. PubMed ID: 3558340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminium bone deposits in normal renal function patients after long-term treatment by plasma exchange.
    Mousson C; Charhon SA; Ammar M; Accominotti M; Rifle G
    Int J Artif Organs; 1989 Oct; 12(10):664-7. PubMed ID: 2807593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium bone disease in patients receiving plasma exchange with contaminated albumin.
    Maharaj D; Fell GS; Boyce BF; Ng JP; Smith GD; Boulton-Jones JM; Cumming RL; Davidson JF
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):693-6. PubMed ID: 3117305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of serum aluminium levels for bone accumulation in haemodialyzed patients.
    Costantini S; Giordano R; Vernillo I; Piccioni A; Zapponi GA
    Ann Ist Super Sanita; 1989; 25(3):457-61. PubMed ID: 2624356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the determination of trace aluminium contamination in dialysis fluids.
    Woolfson AD; Gracey GM
    J Clin Pharm Ther; 1988 Aug; 13(4):243-8. PubMed ID: 3069848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another hazard in plasma aluminium assay by graphite furnace atomic absorption.
    Roberts EA; Wardle CA; Roberts NB
    Ann Clin Biochem; 2001 May; 38(Pt 3):291-2. PubMed ID: 11392512
    [No Abstract]   [Full Text] [Related]  

  • 10. The aluminium content of human serum determined by atomic absorption spectroscopy with a graphite furnace.
    Oster O
    Clin Chim Acta; 1981 Jul; 114(1):53-60. PubMed ID: 7249375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of aluminum in biological fluids by means of graphite furnace atomic absorption spectrometry.
    Smeyers-Verbeke J; Verbeelen D; Massart DL
    Clin Chim Acta; 1980 Nov; 108(1):67-73. PubMed ID: 7449138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of the analytical conditions for the determination of aluminium in human blood plasma or serum by graphite furnace atomic-absorption spectrometry. Part I. Examination of the various analytical conditions.
    Gardiner PE; Stoeppler M; Nürnberg HW
    Analyst; 1985 Jun; 110(6):611-7. PubMed ID: 4037350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood aluminum levels in workers in the aluminum industry].
    Schlatter C; Steinegger A; Rickenbacher U; Hans C; Lengeyl A
    Soz Praventivmed; 1986; 31(2):125-9. PubMed ID: 3716619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of some critical factors affecting determination of aluminum in blood, plasma, or serum by electrothermal atomic absorption spectroscopy.
    Frech W; Cedergren A; Cederberg C; Vessman J
    Clin Chem; 1982 Nov; 28(11):2259-63. PubMed ID: 7127770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of aluminum in biological samples by atomic absorption spectrophotometry with a graphite furnace.
    Gorsky JE; Dietz AA
    Clin Chem; 1978 Sep; 24(9):1485-90. PubMed ID: 688606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions.
    Milliner DS; Shinaberger JH; Shuman P; Coburn JW
    N Engl J Med; 1985 Jan; 312(3):165-7. PubMed ID: 3965935
    [No Abstract]   [Full Text] [Related]  

  • 17. Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
    Chan MK; Varghese Z; Li MK; Wong WS; Li CS
    Int J Artif Organs; 1990 Mar; 13(3):162-8. PubMed ID: 2189835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum determined in plasma and urine by atomic absorption spectroscopy with a transversely heated graphite atomizer furnace.
    Bradley C; Leung FY
    Clin Chem; 1994 Mar; 40(3):431-4. PubMed ID: 8131280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Barr J; Baillod RA
    Arzneimittelforschung; 1994 Apr; 44(4):522-6. PubMed ID: 8011008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential aluminium toxicity in infants fed special infant formula.
    Hawkins NM; Coffey S; Lawson MS; Delves HT
    J Pediatr Gastroenterol Nutr; 1994 Nov; 19(4):377-81. PubMed ID: 7876989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.